Skip to main content

Adenotonsillectomy Tied to Lower Health Care Use in Pediatric Sleep Disordered Breathing

Medically reviewed by Carmen Pope, BPharm. Last updated on March 17, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, March 17, 2025 -- For children with mild sleep disordered breathing (SDB), adenotonsillectomy is associated with reduced all-cause health care utilization, according to a study published online March 17 in JAMA Pediatrics.

Jessie P. Bakker, Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues conducted a randomized clinical trial, Pediatric Adenotonsillectomy Trial for Snoring, from 2016 to 2022 in tertiary care centers in the United States. Participants were aged 3 to 13 years, diagnosed with mild SDB, and had a tonsillar hypertrophy grade of 2 or more.

The analytic sample included 381 children (median age, 6 years). The researchers found that adenotonsillectomy was associated with reductions of 32 and 48 percent in total health care encounters and prescriptions, respectively (mean difference, −1.25 and −2.53 per participant per year, respectively). Fewer office visits and outpatient procedures were the primary drivers of the difference in encounters, rather than reduced hospitalizations or urgent care visits.

"We have demonstrated that early adenotonsillectomy is associated with a 32 percent reduction in all-cause health care encounters and a 48 percent reduction in prescription medications which, along with primary trial results published previously, supports screening for mild SDB and early intervention," the authors write.

Several authors disclosed ties to the biopharmaceutical, medical technology, and publishing industries; one author disclosed holding a related patent.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted March 2025

Read this next

Trend Toward Survival Benefit Seen for REM-Inhibition in ALS

THURSDAY, May 22, 2025 -- For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a...

All-Cause Mortality Higher With Sleep Deprivation in Seniors With Epilepsy

MONDAY, May 19, 2025 -- Older adults with sleep deprivation and epilepsy have an elevated risk for all-cause mortality, according to a study published online April 23 in...

Wearable Sensor Can Monitor Sleep Apnea Treatment Response

MONDAY, May 19, 2025 -- A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.